| 000 | 01452 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517022640.0 | ||
| 264 | 0 | _c20151201 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a2211-0356 | ||
| 024 | 7 |
_a10.1016/j.msard.2014.09.214 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCohen, B A | |
| 245 | 0 | 0 |
_aTherapy Optimization in Multiple Sclerosis: a cohort study of therapy adherence and risk of relapse. _h[electronic resource] |
| 260 |
_bMultiple sclerosis and related disorders _cJan 2015 |
||
| 300 |
_a75-82 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlatiramer Acetate _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aInterferon-beta _xtherapeutic use |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 | _aOutcome Assessment, Health Care |
| 650 | 0 | 4 | _aPatient Compliance |
| 650 | 0 | 4 | _aRecurrence |
| 700 | 1 | _aCoyle, P K | |
| 700 | 1 | _aLeist, T | |
| 700 | 1 | _aOleen-Burkey, M A | |
| 700 | 1 | _aSchwartz, M | |
| 700 | 1 | _aZwibel, H | |
| 773 | 0 |
_tMultiple sclerosis and related disorders _gvol. 4 _gno. 1 _gp. 75-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.msard.2014.09.214 _zAvailable from publisher's website |
| 999 |
_c24721277 _d24721277 |
||